247 related articles for article (PubMed ID: 33963001)
1. Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection.
Jolissaint JS; Soares KC; Seier KP; Kundra R; Gönen M; Shin PJ; Boerner T; Sigel C; Madupuri R; Vakiani E; Cercek A; Harding JJ; Kemeny NE; Connell LC; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
Clin Cancer Res; 2021 Jul; 27(14):4101-4108. PubMed ID: 33963001
[TBL] [Abstract][Full Text] [Related]
2. Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
Boerner T; Drill E; Pak LM; Nguyen B; Sigel CS; Doussot A; Shin P; Goldman DA; Gonen M; Allen PJ; Balachandran VP; Cercek A; Harding J; Solit DB; Schultz N; Kundra R; Walch H; D'Angelica MI; DeMatteo RP; Drebin J; Kemeny NE; Kingham TP; Simpson AL; Hechtman JF; Vakiani E; Lowery MA; Ijzermans JNM; Buettner S; Koerkamp BG; Doukas M; Chandwani R; Jarnagin WR
Hepatology; 2021 Sep; 74(3):1429-1444. PubMed ID: 33765338
[TBL] [Abstract][Full Text] [Related]
3. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839
[TBL] [Abstract][Full Text] [Related]
4. Systemic Chemotherapy with or without Hepatic Arterial Infusion Chemotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Oligometastasis: A Propensity Score-Matched Analysis.
Li Z; Xu R; Chang X; Sun P
J Vasc Interv Radiol; 2024 Mar; 35(3):416-427.e17. PubMed ID: 38008375
[TBL] [Abstract][Full Text] [Related]
5. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations.
Lee SH; Simoneau EB; Karpinets T; Futreal PA; Zhang J; Javle M; Zhang J; Vauthey JN; Lee JS; Estrella JS; Chun YS
Carcinogenesis; 2021 Apr; 42(3):436-441. PubMed ID: 33200197
[TBL] [Abstract][Full Text] [Related]
7. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
Soares KC; Jolissaint JS; McIntyre SM; Seier KP; Gönen M; Sigel C; Nasar N; Cercek A; Harding JJ; Kemeny NE; Connell LC; Koerkamp BG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
Cancer Med; 2023 Jun; 12(11):12272-12284. PubMed ID: 37062071
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.
Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T
Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092
[TBL] [Abstract][Full Text] [Related]
9. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
[TBL] [Abstract][Full Text] [Related]
10. Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinoma.
Martin SP; Drake J; Wach MM; Ruff SM; Diggs LP; Wan JY; Good ML; Dominguez DA; Ayabe RI; Glazer ES; Dickson PV; Davis JL; Deneve JL; Hernandez JM
HPB (Oxford); 2020 Jan; 22(1):129-135. PubMed ID: 31326265
[TBL] [Abstract][Full Text] [Related]
11. ACGH detects distinct genomic alterations of primary intrahepatic cholangiocarcinomas and matched lymph node metastases and identifies a poor prognosis subclass.
Jansen R; Moehlendick B; Bartenhagen C; Tóth C; Lehwald N; Stoecklein NH; Knoefel WT; Lachenmayer A
Sci Rep; 2018 Jul; 8(1):10637. PubMed ID: 30006612
[TBL] [Abstract][Full Text] [Related]
12. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.
Endo I; Gonen M; Yopp AC; Dalal KM; Zhou Q; Klimstra D; D'Angelica M; DeMatteo RP; Fong Y; Schwartz L; Kemeny N; O'Reilly E; Abou-Alfa GK; Shimada H; Blumgart LH; Jarnagin WR
Ann Surg; 2008 Jul; 248(1):84-96. PubMed ID: 18580211
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection of lymph node positive intrahepatic cholangiocarcinoma may not improve survival.
Kizy S; Altman AM; Marmor S; Wirth K; Ching Hui JY; Tuttle TM; Denbo JW; Jensen EH
HPB (Oxford); 2019 Feb; 21(2):235-241. PubMed ID: 30274882
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.
Fisher SB; Patel SH; Kooby DA; Weber S; Bloomston M; Cho C; Hatzaras I; Schmidt C; Winslow E; Staley CA; Maithel SK
HPB (Oxford); 2012 Aug; 14(8):514-22. PubMed ID: 22762399
[TBL] [Abstract][Full Text] [Related]
16. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma.
Nakagawa T; Kamiyama T; Kurauchi N; Matsushita M; Nakanishi K; Kamachi H; Kudo T; Todo S
World J Surg; 2005 Jun; 29(6):728-33. PubMed ID: 15880276
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastasis in intrahepatic cholangiocarcinoma.
Yamamoto M; Takasaki K; Yoshikawa T
Jpn J Clin Oncol; 1999 Mar; 29(3):147-50. PubMed ID: 10225697
[TBL] [Abstract][Full Text] [Related]
18. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
Rimini M; Fabregat-Franco C; Persano M; Burgio V; Bergamo F; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Rizzato M; Nichetti F; Lai E; Cappetta A; Macarulla T; Fassan M; De Braud F; Pretta A; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
Target Oncol; 2023 Jan; 18(1):139-145. PubMed ID: 36689074
[TBL] [Abstract][Full Text] [Related]
20. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.
Nakayama T; Tsuchikawa T; Shichinohe T; Nakamura T; Ebihara Y; Hirano S
World J Surg; 2014 Jul; 38(7):1763-8. PubMed ID: 24378552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
